A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells.
Ontology highlight
ABSTRACT: The CRISPR-Cas9 system has emerged as a powerful and efficient tool for genome editing. An important drawback of the CRISPR-Cas9 system is the constitutive endonuclease activity when Cas9 endonuclease and its sgRNA are co-expressed. This constitutive activity results in undesirable off-target effects that hinder studies using the system, such as probing gene functions or its therapeutic use in humans. Here, we describe a convenient method that allows temporal and tight control of CRISPR-Cas9 activity by combining transcriptional regulation of Cas9 expression and protein stability control of Cas9 in human stem cells. To achieve this dual control, we combined the doxycycline-inducible system for transcriptional regulation and FKBP12-derived destabilizing domain fused to Cas9 for protein stab
SUBMITTER: Park SB
PROVIDER: S-EPMC9112054 | biostudies-literature | 2022 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA